Anti-AKT1 (phospho T308) antibody [AktT308-G12]
- 20ul selling size
- Recombinant
- Lab Essentials
- What is this?
Be the first to review this product! Submit a review
|
(6 Publications)
Rabbit Recombinant Monoclonal AKT1 phospho T308 antibody. Suitable for Flow Cyt, WB and reacts with Mouse, Rat, Human samples. Cited in 6 publications. Immunogen corresponding to Synthetic Peptide within Human AKT1 phospho T308.
View Alternative Names
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (AB278565)
Peptide blocking flow cytometric analysis of K562 cells secondary antibody only negative control (light blue) or treated with LY294002 (red) or with IFNa + IL-4 + pervanadate (green) or LY294002 and blocked with phospho-peptide (black) or IFN+IL4+Pv and blocked with phospho peptide (gold) or LY294002 and blocked with non-phospho peptide (dark blue) or IFN+IL4+Pv and blocked with non-phospho peptide (purple) using ab278565 at 0.5 µg/mL.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (AB278565)
Flow cytometric analysis of NIH3T3 cells treated with LY294002+U0126+wortmanin and stained with secondary antibody as negative control (blue) or treated with LY294002+U0126+wortmain (red) or with PDGF (green) and stained using ab278565 at 0.01 µg/mL.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (AB278565)
Flow cytometric analysis of C6 cells unstained and treated with imatinib as negative control (blue) or treated with imatinib or with PDGF (green) using ab278565 at 0.01 µg/mL.
- WB
Supplier Data
Western blot - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (AB278565)
All lanes:
Western blot - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (ab278565) at 0.1 µg/mL
Lane 1:
NIH3T3 cell extract treated with 20% FBS
Lane 2:
NIH3T3 cell extract untreated with 20% FBS
Predicted band size: 55 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (AB278565)
All lanes:
Western blot - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (ab278565) at 0.1 µg/mL
Lane 1:
293T cell extract treated with 20% FBS
Lane 2:
293T cell extract untreated with 20% FBS
Predicted band size: 55 kDa
false
- WB
CiteAb
Western blot - Anti-AKT1 (phospho T308) antibody [AktT308-G12] (AB278565)
AKT1 (phospho T308) western blot using anti-AKT1 (phospho T308) antibody [AktT308-G12] ab278565. Publication image and figure legend from Liu, H., Han, L., et al., 2022, J Immunol Res, PubMed 36106050.
ab278565 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab278565 please see the product overview.
FBXL16 dephosphorylated cyclin D1 by regulating Akt1/GSK-3β signaling pathway via binding PP2AB55α. (a) Western blot analyses of cyclin D1 and phosphor-cyclin D1 (T286) in Ishikawa/MPA with shNC and shFBXL16 cells. (b) Coimmunoprecipitation of E3 ligase and cyclin D1 in Ishikawa/MPA cells with the shRNA-NC or shFBXL16 group. (c) Coimmunoprecipitation of FBXL16, PP2A-A α/β, PP2A-B55α, and PP2A-C in Ishikawa/MPA cells with the shRNA-NC or shFBXL16 group. (d) Western blot analyses of phosphor-cyclin D1 (T286) and GSK3β/AKT1 pathway in Ishikawa/MPA with shNC and shFBXL16 cells. Results are presented as mean ± SD. *p < 0.05. **p < 0.01. ***p < 0.001.
false
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT1 regulates a broad spectrum of cellular functions through signaling pathways. It is an important player in the phosphatidylinositol 3-kinase (PI3K) and AKT pathway forming part of a complex involved in promoting cell survival and growth. AKT1 interacts closely with other proteins such as mTOR influencing cellular metabolism and autophagy. The phosphorylation state of AKT1 is critical for its activity with modifications like p-AKT S473 impacting its interaction with cellular substrates.
Pathways
AKT1 participates in the PI3K/AKT/mTOR signaling cascade instrumental in cell proliferation and metabolism. AKT1 integrates signals from insulin and growth factors modulating pathways that control cell growth and glucose uptake. This pathway involves proteins like mTOR and phospho-AKT which coordinate cellular responses to external stimuli. AKT1’s phosphorylation at serine 473 and the involvement of AKT1 E17K a gain-of-function mutation influence these pathways significantly.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
World journal of gastrointestinal oncology 17:105264 PubMed40697228
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1284752 PubMed38860166
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 17:91 PubMed38678269
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36430265
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology research 2022:7372202 PubMed36106050
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:4308 PubMed35879297
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com